Research Library
GHK-CuTissue Repair & Regeneration Research

GHK-Cu: A Research Reference Dossier

A research-reference dossier on GHK-Cu (copper tripeptide), distinguishing GHK from its copper complex and summarizing cell, animal, and limited human dermatologic evidence.

Peptide Underground

Overview

GHK (glycyl-L-histidyl-L-lysine) is an endogenous tripeptide with high affinity for Cu2+, forming the GHK-Cu (copper tripeptide) complex. GHK and GHK-Cu are related but distinct: GHK-Cu is the copper-bound complex most often studied for tissue-repair and dermatologic effects. GHK-Cu is not an FDA-approved drug.

Biological Target / Mechanism

GHK-Cu modulates multiple cellular pathways — stimulating collagen/glycosaminoglycan synthesis, promoting angiogenesis and wound-healing-associated cell migration, and influencing gene expression — in part via copper-dependent activity. Mechanism is primarily characterized in cell and animal models.

Research Areas

Wound healing, skin regeneration/dermatology, and tissue repair. Evidence levels: extensive in vitro and animal data; limited human clinical evidence.

Evidence Overview

Cell and animal studies (reviewed by Pickart and others) report accelerated wound healing, increased collagen and angiogenesis, and anti-inflammatory effects. Some human dermatologic and wound-healing observations exist, but robust randomized controlled trials are limited; cosmetic-use data should not be equated with therapeutic efficacy.

Regulatory / Development Context

GHK-Cu is used in cosmetic contexts and is not an FDA-approved drug. Research-grade GHK-Cu is distinct from any cosmetic or therapeutic product.

Analytical / Research Considerations

Distinguish GHK from GHK-Cu in documentation. Research-grade material is handled under appropriate laboratory storage. Research-grade material is handled under appropriate laboratory storage and documentation. No purity, identity, stability, sterility, batch, or COA claims are made here for any Peptide Underground material.

Limitations

Most supportive data are preclinical or cosmetic-context; human clinical evidence is limited. Findings should not be presented as established therapeutic efficacy.

References

  1. Pickart L, et al. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration (review). https://pmc.ncbi.nlm.nih.gov/articles/PMC4508379/
  2. Regenerative and Protective Actions of the GHK-Cu Peptide (review). https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/
  3. Pickart L, et al. Growth-modulating plasma tripeptide... Nature 1980. https://pubmed.ncbi.nlm.nih.gov/7453802/
  4. Simeon A, et al. Expression of glycosaminoglycans... modulation by GHK-Cu. J Invest Dermatol 2000. https://pubmed.ncbi.nlm.nih.gov/11121126/

Research Library materials are provided for informational and research-reference purposes only. They do not constitute medical advice, treatment recommendations, or instructions for human use.

Peptide Underground

Independent information. Shared testing. Transparent documentation.

Peptide Underground organizes research compound information and analytical documentation from participating group-testing programs, including batch-specific laboratory reports and Certificates of Analysis when available.

Peptide Underground is an information and documentation platform. It does not manufacture, sell, or test products.

support@peptideunderground.com

peptideunderground.com

Legal

For Research Use Only

Compounds referenced on Peptide Underground are intended for laboratory and research purposes only. They are not intended to diagnose, treat, cure, or prevent any disease and are not intended for human consumption.

© 2026 Peptide Underground. All rights reserved.

For Research Use Only — Not for Human Consumption